Grant: CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
McGill University
$62,500.00
Identification of Stat1 signaling pathway(s) involved in mediating tumor escape from immune surveillance.
FY 2022-23
Summary
This proposal investigates the role of Stat1 as a critical regulator of breast cancer dormancy through suppression of immune
surveillance. Given that breast cancer dormancy contributes to drug resistance and relapse, the identification of key molecular
events governing dormancy is therefore of great importance to breast cancer patients. Our vision is that by understanding the
breast cancer dormancy will enhance our knowledge of this important new area. Studying the nature of these changes and
* Cancer Type
* Keywords
characterizing compensatory mechanisms, we will uncover information that could lead to new clinical strategies that would
synergize with current breast cancer therapeutic strategies.
Department
Program
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
490747
Name
Muller William J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Identification of Stat1 signaling pathway(s) involved in mediating tumor escape from immune surveillance.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$62,500
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Res. Grants - Breast Cancer
Keyworddelim
Immunotherapy; Metastasis; Oncolytic Viruses & Immunotherapy
Abstract
This proposal investigates the role of Stat1 as a critical regulator of breast cancer dormancy through suppression of immune
surveillance. Given that breast cancer dormancy contributes to drug resistance and relapse, the identification of key molecular
events governing dormancy is therefore of great importance to breast cancer patients. Our vision is that by understanding the
breast cancer dormancy will enhance our knowledge of this important new area. Studying the nature of these changes and
* Cancer Type
* Keywords
characterizing compensatory mechanisms, we will uncover information that could lead to new clinical strategies that would
synergize with current breast cancer therapeutic strategies.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Muller, William J
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $62,500~ $0~